Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (13314)	10/5/2004 3:45:13 PM
From: OldAIMGuy	of 52153

Hi B, Re: CHIR Flu Vaccine....... This will impact current year's earnings by about 25% to 33%. Estimates are that earnings will drop from around $1.50/share to around $1.00 to $1.20. I've held shares of CHIR for years. It's been somewhat lacklustre for a couple of years now. I did have an outstanding order to add about 10% to my position if the price fell below about $38. However, being an open order it filled at $30 when trading opened on it. So, if nothing else, I can play the bounce. I'd still like to be out of the stock some time in the future. There's been better plays in recent years. I've never lost money on CHIR, but in the last few years, it's been range bound tightly enough to make it harder to profit trading shares. Best regards, Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next